Seroprevalence of neutralizing antibodies to adenovirus type 5 among children in India: Implications for recombinant adenovirus-based Vaccines

被引：28
作者：
Appaiahgari, Mohan Babu
Pandey, Ravindra Mohan
Vrati, Sudhanshu
机构：
[1] Natl Inst Immunol, JNU Complex, New Delhi 110067, India
[2] All India Inst Med Sci, Dept Biostat, New Delhi 110016, India
来源：
CLINICAL AND VACCINE IMMUNOLOGY | 2007年 / 14卷 / 08期
关键词：
D O I：
10.1128/CVI.00173-07
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We determined the levels of adenovirus 5 (Ad5) neutralizing antibodies in children in India less than 2 years of age. The results clearly show an age-dependent increase in Ad5-specitic immunity, with 7- to 12-month-old children having the lowest levels of Ad5 immunity. This opens up the scope for the use of recombinant Ad5-based vaccines in this age group.
引用
收藏
页码：1053 / 1055
页数：3
相关论文
共 50 条
  • [31] Use of adenovirus type-5 vector vaccines in COVID-19: potential implications for metabolic health?
    Tsilingiris, Dimitrios
    Vallianou, Natalia G.
    Karampela, Irene
    Muscogiuri, Giovanna
    Dalamaga, Maria
    [J]. MINERVA ENDOCRINOLOGY, 2022, 47 (03): : 264 - 269
  • [32] A Human Type 5 Adenovirus-Based Trypanosoma cruzi Therapeutic Vaccine Reprograms Immune Response and Reverses Chronic Cardiomyopathy
    Pereira, Isabela Resende
    Vilar-Pereira, Glaucia
    Marques, Virginia
    da Silva, Andrea Alice
    Caetano, Braulia
    Moreira, Otacilio Cruz
    Machado, Alexandre Vieira
    Bruna-Romero, Oscar
    Rodrigues, Mauricio Martins
    Gazzinelli, Ricardo Tostes
    Lannes-Vieira, Joseli
    [J]. PLOS PATHOGENS, 2015, 11 (01) : 1 - 26
  • [33] A universal recombinant adenovirus type 5 vector-based COVID-19 vaccine
    Li, Xingxing
    Peng, Qinhua
    Liu, Xinyu
    Xu, Hongshan
    Liu, Jingjing
    Wu, Xiaohong
    Ye, Qiang
    Li, Min
    Li, Yuhua
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [34] Adenovirus-associated antibodies in UK cohort of hemophilia patients: A seroprevalence study of the presence of adenovirus-associated virus vector-serotypes AAV5 and AAV8 neutralizing activity and antibodies in patients with hemophilia A
    Stanford, Sophia
    Pink, Ruth
    Creagh, Desmond
    Clark, Amanda
    Lowe, Gillian
    Curry, Nicola
    Pasi, John
    Perry, David
    Fong, Sylvia
    Hayes, Gregory
    Chandrakumaran, Kandiah
    Rangarajan, Savita
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2019, 3 (02) : 261 - 267
  • [35] ADENOVIRUS HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ENVELOPE RECOMBINANT VACCINES ELICIT HIGH-TITERED HIV-NEUTRALIZING ANTIBODIES IN THE DOG-MODEL
    NATUK, RJ
    CHANDA, PK
    LUBECK, MD
    DAVIS, AR
    WILHELM, J
    HJORTH, R
    WADE, MS
    BHAT, BM
    MIZUTANI, S
    LEE, S
    EICHBERG, J
    GALLO, RC
    HUNG, PP
    ROBERTGUROFF, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) : 7777 - 7781
  • [36] Spike nanoparticle and recombinant adenovirus 5 vaccines induce specific antibodies against the Middle East respiratory syndrome coronavirus (MERS-CoV)
    Park, Hyo-Jung
    Lee, Eun-Young
    Jung, SeoYeon
    Ko, Hae Li
    Lee, Sang-Myeong
    Nam, Jae-Hwan
    [J]. JOURNAL OF IMMUNOLOGY, 2017, 198 (01)
  • [37] Comparative Profiles of SARS-CoV-2 Spike-Specific Human Milk Antibodies Elicited by mRNA- and Adenovirus-Based COVID-19 Vaccines
    Yang, Xiaoqi
    Fox, Alisa
    DeCarlo, Claire
    Norris, Caroline
    Griffin, Samantha
    Wedekind, Sophie
    Flanagan, James M.
    Shenker, Natalie
    Powell, Rebecca L.
    [J]. BREASTFEEDING MEDICINE, 2022, 17 (08) : 638 - 646
  • [38] High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines
    Wright, N.
    Jackson, F. R.
    Niezgoda, M.
    Ellison, J. A.
    Rupprecht, C. E.
    Nel, L. H.
    [J]. VACCINE, 2013, 31 (38) : 4177 - 4182
  • [39] Seroprevalence of measles, mumps & rubella antibodies among 5-10 years old children in north India
    Gupta, Madhu
    Tripathy, Jaya Prasad
    Verma, Madhur
    Singh, Mini P.
    Kaur, Ramanpreet
    Ratho, R. K.
    Kumar, Rajesh
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2019, 149 (03) : 396 - 403
  • [40] Broadly neutralizing monoclonal antibodies against human adenovirus types 55, 14p, 7, and 11 generated with recombinant type 11 fiber knob
    Tian, Xingui
    Fan, Ye
    Liu, Zhenwei
    Zhang, Ling
    Liao, Jiayi
    Zhou, Zhichao
    Li, Xiao
    Liu, Tiantian
    Liu, Wenkuan
    Qiu, Hongling
    Zhou, Rong
    [J]. EMERGING MICROBES & INFECTIONS, 2018, 7
12345